Form D · Pharmaceuticals
VR1 Corp
New York, NY · CIK 0001561045
Offering snapshot reported Sep 16, 2014 · SEC filing
- Reported sold
- $900K Offering amount: $930K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 19, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2014 | Initial | $900,279 | No comparison | 7 | SEC filing |
| May 13, 2014 | Amendment | $335,000 | $185,000vs Dec 19, 2013 | 10 | SEC filing |
| Dec 19, 2013 | Amendment | $150,000 | $87,000vs Oct 28, 2013 | 7 | SEC filing |
| Oct 28, 2013 | Initial | $63,000 | No comparison | 3 | SEC filing |
| Jul 1, 2013 | Initial | $530,000 | No comparison | 6 | SEC filing |
| Nov 7, 2012 | Initial | $624,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224825
Source: Form D, filed Sep 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anjan Chatterjee | Director, Executive |
| Michele Harris | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
68 East 131 St Street, Suite 307
New York, NY, 10037
New York, NY, 10037